Cefoxitin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from ... |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | ||
Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. | Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. See also [https://en.wikipedia.org/wiki/Cefoxitin Cefoxitin]. | ||
[[7kcx]]. | [[7kcx]]. | ||
Revision as of 14:56, 27 March 2024
| ||||||||||||
